Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism

Inhibition of NF-κB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells

(2012) In-Kyung Jeong et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

The Effects of Palmitate on Hepatic Insulin Resistance Are Mediated by NADPH Oxidase 3-derived Reactive Oxygen Species through JNK and p38MAPKPathways

(2010) Dan Gao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance

(2010) Giovanni Tarantino   WORLD JOURNAL OF GASTROENTEROLOGY

Activation of Peroxisome Proliferator-Activated Receptor  /  Inhibits Lipopolysaccharide-Induced Cytokine Production in Adipocytes by Lowering Nuclear Factor- B Activity via Extracellular Signal-Related Kinase 1/2

(2008) R. Rodriguez-Calvo et al.   DIABETES

PPAR  regulates multiple proinflammatory pathways to suppress atherosclerosis

(2008) G. D. Barish et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Suppression of Pro-inflammatory Adhesion Molecules by PPAR-δ in Human Vascular Endothelial Cells

(2007) Yanbo Fan et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY